BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170626
DTEND;VALUE=DATE:20170727
DTSTAMP:20260729T180244
CREATED:20170626T072152Z
LAST-MODIFIED:20170626T072259Z
UID:18459-1498435200-1501113599@ces.b2sg.org
SUMMARY:Postdoc - Cancer Epigenetics
DESCRIPTION:One fully funded postdoctoral position is available to study the role of autophagy adaptors in the control of the transcriptional activity of key mediators of stromal function in cancer. The project is based on our recent publication in Cancer Cell (Duran et al.\, 2016) and will use mouse models and cell based studies and the interrogation of human cancer samples. This is part of an ongoing collaboration between the laboratories of Jorge Moscat and Maria T. Diaz-Meco. \nThese laboratories are part of the Cancer Metabolism and Signaling Networks Program\, an essential piece of the vibrant Sanford Burnham Prebys NCI-designated Cancer Center (http://www.sbpdiscovery.org/research/centers/cancer/cdsn/Pages/Home.aspx). \nOur goal is to unravel the mechanistic crosstalk between stromal\, immune\, and tumor cells\, to identify potential new targets for innovative cancer therapies. Additional publications by our labs describing ongoing studies in this area have appeared in for example: Mol. Cell (2011\, 2013)\, Cell Metab. (2006\, 2011\, 2014)\, Cell (2009\, 2011\, 2013)\, Cell Reports (2015\, 2016)\, and Cancer Cell (2008\, 2014\, 2016). \nRequired Experience \nWe are looking for highly motivated and enthusiastic individuals who are interested in this very competitive topic\, and with expertise in studies related to transcriptional activity and epigenetics. Candidates must have a Ph.D. or M.D. degree and a publication record demonstrating expertise in this area.  \nInterested applicants should submit a single PDF file containing CV\, a brief description of research accomplishments\, interests\, and career goals\, and contact information (e-mail address and phone number) of three references. \nThe position is available starting immediately\, and offers a very competitive health and retirement package. \nSanford Burnham Prebys Medical Discovery Institute is an Equal Opportunity employer – M/F/Veteran/Disability – committed to the hiring\, advancement and fair treatment of all individuals. All qualified applicants will receive consideration for employment without regard to race\, color\, religion\, sex\, sexual orientation\, gender identity\, national origin\, age\, disability\, protected veteran status\, or any other protected status as designated by federal\, state or local law. For additional information about your rights as an applicant\, click HERE.
URL:https://ces.b2sg.org/event/sanford-burham-postdoc/
LOCATION:Sanford Burnham Prebys Medical Discovery Institute\, 10901 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/sanford-burham-sbp.jpg
END:VEVENT
END:VCALENDAR